EMA Helps Trial Sponsors Categorize IMP Changes Under New Rules
EU CTR Introduces Concept Of Non-Substantial Changes Relevant For Supervision
Executive Summary
The European Medicines Agency is inviting feedback on changes to two guidelines that will help trial sponsors correctly classify quality-related changes to their investigational medicinal products as per the requirements of the EU Clinical Trial Regulation.